Genomics and Precision Medicine Expo – taking place on May 23-24 at ExCeL London – has announced its top 5 ‘not to be missed’ highlights for this year’s inaugural conference.
The event, which is being run in partnership with Genomics England, will explore the latest advancements and developments in genome sequencing and genomic testing, and the immediate and future potential for the development of precision medicine in the NHS and beyond.
Content throughout the two days will cover a variety of topics, including discovery, research, development and regulatory assessment, through to delivery, supply and patient referral.
Lucy Clarke, Event Manager of Genomics and Precision Medicine Expo, said:
“The event is a unique chance to discover critical updates, gain practical learnings that you can apply to your own work, and share insights with like-minded peers across patient care and science.
“With the UK being a key world leader in genomics testing and life sciences, there is a wealth of knowledge to be shared at the Genomics and Precision Medicine Expo.”
Highlights over the two days include:
Day one – May 23
- Precision cancer medicine: progress, limitations and opportunities (11:45 – 12:30). Precision medicine is the desire to tailor each person’s treatment according to the underlying biology of their disease. In this talk, Elaine will introduce the problems we face, describe where we’re making progress, and outline six unanswered questions. She will conclude by offering three partial solutions to improve and refine our use of the tools and treatments available to us.
- Implementing whole genome sequencing into routine clinical practice (2:00-2:30). All children in the UK with cancer are eligible for somatic and germline whole genome sequencing (WGS) via the NHS Genomic Medicine Service. In this talk, Dr Jack Bartram, a consultant paediatric haematologist at Great Ormond Street Hospital for Children (GOSH), will describe experiences of using WGS for haematological malignancies to obtain, analyse and clinically integrate results in a meaningful timeframe.
- Panel discussion: Navigating patient consent in cancer genomics (3:45-4:30). The use of genomic testing in routine care brings benefits for patient care and treatment, but it can also present new challenges for clinicians around consent. In this panel session involving representatives from Genomics England and The Royal Marsden NHS Foundation Trust, we will explore different scenarios and approaches to consenting cancer patients for genomic testing.
Day two – May 24
- The role of nurses in transforming genomic healthcare (13:15 – 14:00). The application of genomics in everyday practice is now a reality in cancer care and in rare diseases. Tootie Bueser, Director for Nursing & Midwifery and Chief Nurse – Southeast Genomic Medicine Service Alliance and North Thames Genomic Medicine Service Alliance will explore how nurses have an important role in transforming care through genomics and need access to education, training and other resources to maximise this opportunity.
- Pharmacogenomics (14:15 – 15:00). Hosted by Nisha Shaunak, Associate Chief Pharmacist – Cancer, TRU and Surgery Clinical Group, Guy’s & St Thomas’ NHS Foundation Trust.
Co-located with the award-winning Oncology Professional Care, Genomics and Precision Medicine Expo is free to attend for registered healthcare professionals and individuals working in the field of genomics and precision medicine (excluding commercial companies) and is fully CPD-accredited.
The co-located events feature 150+ sessions across seven focused theatres with leading product and service providers showcasing the latest innovations on the exhibition floor.
Genomics and Precision Medicine Expo will capture the interest of Public Health and ICS leaders, CCIOs within the NHS and private sector, clinicians working in acute and primary care who wish to develop their knowledge and understanding of the fast-moving developments in this sector, and clinical and biomedical scientists.
Attendance is free for UK healthcare professionals and individuals working in the fields of genomics and precision medicine (in non-commercial roles) – simply register here: genomicsprecisionmedicine.co.uk
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI6 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds